Publications Office of the EU
Supply of medicinal products - 7 parts - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Supply of medicinal products - 7 parts Text automatically translated in your browsing language Automatically translated

  • Published
    08/11/2024
  • Deadline
    26/11/2024
  • Opening of tenders
    26/11/2024
  • Today
    09/12/2024
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
Instytut Hematologii i Transfuzjologii
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL911 Miasto Warszawa
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
7
Tender reference number
IHIT/P/070/2024
Description

Supply of medicinal products - 7 parts Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://ihit.ezamawiajacy.pl
Tenders may be submitted
Electronic submission: required
https://ihit.ezamawiajacy.pl
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
26/11/2024 09:15
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.